Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intracept Minimally-invasive PROcedure for VErtebrogenic Back Pain

NCT06827262 is registered in ClinicalTrials.gov with Boston Scientific Corporation as lead sponsor.

NCT NCT06827262
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06827262 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intracept Minimally-invasive PROcedure for VErtebrogenic Back Pain
Lead sponsor
Boston Scientific Corporation
Phase
Observational
Overall status
Recruiting
Start date
March 26, 2025
Completion date
July 31, 2034
Enrollment
1,500 (estimated)
Sites
22

Conditions

As the registry lists them; a condition with its own page is linked.

chronic low-back pain, vertebrogenic pain syndrome